Clinical Trials · NCT01990040

Registry for Participants With Short Bowel Syndrome

Name: Registry for Participants With Short Bowel Syndrome
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingN/ATeduglutide

Phase: N/A
Recruitment status: Active Not Recruiting
Sponsor: Shire
Enrollment: 1,806
Start date: Jun 2014
Locations: 1 site, United States
Primary endpoint: Occurrence of Colorectal Cancer in Short Bowel Syndrome (SBS) Participants With a Remnant Colon Currently Being Treated With or Ever Having Been Treated With Teduglutide

View Teduglutide compound reference